Your browser doesn't support javascript.
loading
Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study.
Jenei, Kristina; Raymakers, Adam J N; Bayle, Arnaud; Berger-Thürmel, Karin; Cherla, Avi; Honda, Kazunori; Jackson, Christopher C G A; Karikios, Deme; Trapani, Dario; Berry, Scott; Gyawali, Bishal.
Afiliação
  • Jenei K; Department of Health Policy, London School of Economics and Political Science, London, UK.
  • Raymakers AJN; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Bayle A; Oncostat U1018, Inserm, Paris-Saclay University, Gustave Roussy, Villejuif, France.
  • Berger-Thürmel K; Department of Hematology/Oncology, Ludwig-Maximilians-University Hospital, Munich, Germany.
  • Cherla A; Department of Health Policy, London School of Economics and Political Science, London, UK.
  • Honda K; Department of Clinical Oncology, Aichi Cancer Center, Nagoya, Japan.
  • Jackson CCGA; Otago Medical School, University of Otago, Dunedin, New Zealand.
  • Karikios D; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
  • Trapani D; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haematology, University of Milan, Milan, Italy.
  • Berry S; Department of Oncology, Queen's University, Kingston, ON, Canada.
  • Gyawali B; Department of Oncology, Queen's University, Kingston, ON, Canada; Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada; Department of Public Health Sciences, Queen's University, Kingston, ON, Canada. Electronic address: gyawali.bishal@queensu.
Lancet Oncol ; 24(6): 624-635, 2023 06.
Article em En | MEDLINE | ID: mdl-37269843

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Avaliacao_economica / Avaliacao_tecnologia Bases de dados: MEDLINE Assunto principal: Avaliação da Tecnologia Biomédica / Neoplasias Tipo de estudo: Guideline / Health_technology_assessment / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa / Oceania Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Avaliacao_economica / Avaliacao_tecnologia Bases de dados: MEDLINE Assunto principal: Avaliação da Tecnologia Biomédica / Neoplasias Tipo de estudo: Guideline / Health_technology_assessment / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa / Oceania Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido